聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 21 分钟 33 秒 前

Denali Therapeutics Launches with Initial Investment to Discover and Develop Treatments for Neurodegenerative Diseases

周四, 05/14/2015 - 14:15
SAN FRANCISCO, May 14, 2015 -- (Healthcare Sales & Marketing Network) -- Denali Therapeutics Inc. ("Denali"), a new biotechnology company focused on developing effective therapies for neurodegenerative diseases, announced today that it has launc...
Biopharmaceuticals, Neurology, Venture Capital
Denali Therapeutics, neurodegenerative, Alzheimer's disease, Parkinson's disease

InVivo Therapeutics Reports Update of First Two Spinal Cord Injury Patients Implanted with Neuro-Spinal Scaffold

周四, 05/14/2015 - 14:07
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--InVivo Therapeutics Holdings Corp. (NVIV) today announced a six-month post-implant update for the first study patient and a three-month post-implant update for the second study patient in the compan...
Devices, Neurosurgery
InVivo Therapeutics Holdings Corp, Neuro-Spinal Scaffold, spinal cord injury

OncoCyte Corporation Completes Equity Financing Round

周四, 05/14/2015 - 14:02
Capital to fund further development and commercialization efforts of cancer diagnostic tests by BioTime subsidiary ALAMEDA, Calif.--(Healthcare Sales & Marketing Network)--BioTime, Inc. (NYSE MKT:BTX) and its subsidiary OncoCyte Corporation today announ...
Diagnostics, Oncology, Venture Capital
BioTime, OncoCyte, PanC-Dx

PENTAX Medical Reaffirms Commitment to Work with FDA and Industry Partners To Address Duodenoscope Infection Issues

周四, 05/14/2015 - 13:54
MONTVALE, N.J., May 14, 2015 -- (Healthcare Sales & Marketing Network) -- As the FDA Advisory Panel on Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee prepares to meet, PENTAX Medical affirms its commitment to work wit...
Devices, Gastroenterology, Urology
PENTAX Medical

EPIRUS Biopharmaceuticals and mAbxience Sign Latin America Distribution Deal for Infliximab Biosimilar, BOW015

周四, 05/14/2015 - 13:41
BOSTON, May 14, 2015 -- (Healthcare Sales & Marketing Network) -- EPIRUS Biopharmaceuticals, Inc. (EPRS) and mAbxience, a biopharmaceutical company specialized in research, development and manufacturing of biosimilars, entered into a development and future...
Biopharmaceuticals, Distribution
EPIRUS Biopharmaceuticals, mAbxience, biosimilar, infliximab

St. Jude Medical Expands Portfolio of MRI-Compatible Devices to High Voltage in Europe

周三, 05/13/2015 - 22:19
CE Mark approvals further strengthen the company’s portfolio of MRI-compatible devices ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, today announced CE Mark approval of expanded l...
Devices, Cardiology, Regulatory
St. Jude Medical, Assurity MRI, Endurity MRI

Mederi Therapeutic's Stretta Becomes World's Most Widely-Used Non-Surgical Treatment For Chronic GERD

周三, 05/13/2015 - 14:49
18,000 Stretta procedures performed since introduction, making Stretta the safest and most widely used endoluminal therapy for GERD Stretta expands reach with regulatory approvals added in large international markets NORWALK, Conn. , May 13, 2015 -- ...
Devices, Gastroenterology
Mederi Therapeutics, Stretta , GERD

Jeng-Dar Yang Ph.D. Joins Actinium Pharmaceuticals as Vice President of Pharmaceutical Development

周三, 05/13/2015 - 14:41
New Executive Brings Wealth of Experience and Impressive Track Record as Company Approaches Pivotal Trial NEW YORK, NY--(Healthcare Sales & Marketing Network) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or "the Company&q...
Biopharmaceuticals, Personnel
Actinium Pharmaceuticals

Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger

周二, 05/12/2015 - 15:45
MILAN and HOUSTON, May 12, 2015 -- (Healthcare Sales & Marketing Network) -- Sorin S.p.A., (MTA; Reuters Code: SORN.MI "Sorin"), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASD...
Devices, Neurology, Mergers & Acquisitions, Personnel
Cyberonics, Sorin Group, neuromodulation

Paradigm Spine, LLC Announces The Publication Of Long-term Results Of Level 1 Data For coflex(R) Interlaminar Stabilization(R)

周二, 05/12/2015 - 15:40
NEW YORK, May 12, 2015 -- (Healthcare Sales & Marketing Network) -- Paradigm Spine, LLC, a leader in providing solutions for the treatment of advanced degenerative lumbar spinal stenosis announces publication on May 11, 2015 by Hyun Bae, M.D., et al of &q...
Devices, Orthopaedic, Neurosurgery
Paradigm Spine, coflex, Interlaminar Stabilization

Aspyrian Therapeutics Inc. Announces FDA Acceptance of an Investigational New Drug Application for RM-1929, a First-in-Class, Precision-Targeted Therapy for Cancer

周二, 05/12/2015 - 14:26
SAN DIEGO, May 12, 2015 -- (Healthcare Sales & Marketing Network) -- Aspyrian Therapeutics Inc., a drug development company creating precision-targeted therapies to treat cancer based on its proprietary Photoimmunotherapy platform, today announced the U.S...
Biopharmaceuticals, Oncology, FDA
Aspyrian Therapeutics, Photoimmunotherapy

Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer

周二, 05/12/2015 - 14:19
Evofosfamide is an investigational compound currently in Phase III trials Advanced pancreatic cancer is second indication to receive FDA fast track designation for evofosfamide ROCKLAND, Massachusetts, May 12, 2015 -- (Healthcare Sales & Marketing Ne...
Biopharmaceuticals, Oncology, FDA
EMD Serono, Merck KGaA, evofosfamide, pancreatic cancer

Autonomic Technologies Raises USD 38M in a Transatlantic Series D Financing

周二, 05/12/2015 - 14:03
REDWOOD CITY, CA--(Healthcare Sales & Marketing Network) - Autonomic Technologies™, Inc. (ATI™), developer and manufacturer of Pulsante™, a microstimulator to treat severe headaches, today announced the closing of a series D round of financing for $38M. Th...
Devices, Neurology, Venture Capital, Personnel
Autonomic Technologies, Pulsante, microstimulator

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong